Silencing S1P1 receptors regulates collagen-V reactive lymphocyte-mediated immunobiology in the transplanted lung

American Journal of Transplantation

Volumn 8, Issue 3, 2008, Pages 537-546

  Chiyo, M ^a,b   Iwata, T ^a,b   Webb, T J ^a   Vasko, M R ^a   Thompson, E L ^a   Heidler, K M ^a   Cummings, O W ^a   Yoshida, S ^b   Fujisawa, T ^b   Brand, D D ^c   Wilkes, D S ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHIBA UNIVERSITY   (Japan)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Autoimmunity; Cell trafficking; Lung; T cells; Transplantation

Indexed keywords

ALLOANTIGEN; CELL ADHESION MOLECULE; COLLAGEN TYPE 5; GAMMA INTERFERON; INTERLEUKIN 10; MESSENGER RNA; SMALL INTERFERING RNA; SPHINGOSINE 1 PHOSPHATE 1 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; IMMUNE RESPONSE; IMMUNOBIOLOGY; IMMUNOREGULATION; INTERFERON PRODUCTION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MALE; MEDIASTINUM LYMPH NODE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RECIPIENT;

ADOPTIVE TRANSFER; ANIMALS; CELL MOVEMENT; COLLAGEN TYPE V; GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; RATS; RATS, INBRED WKY; RECEPTORS, LYSOSPHINGOLIPID; RNA, SMALL INTERFERING; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 39649086029     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.02116.x     Document Type: Article

References (42)

1. Estenne M, Kotloff RM. Update in transplantation 2005. Am J Respir Crit Care Med 2006 173 : 593 598.
2. Haque MA, Mizobuchi T, Yasufuku K et al. Evidence for immune responses to a self-antigen in lung transplantation: Role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol 2002 169 : 1542 1549.
3. Mizobuchi T, Yasufuku K, Zheng Y et al. Differential expression of Smad7 transcripts identifies the CD4+CD45RC high regulatory T cells that mediate type V collagen-induced tolerance to lung allografts. J Immunol 2003 171 : 1140 1147.
4. Burlingham WJ, Love RB, Jankowska-Gan E et al. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007 117 : 3498 3506.
5. Yoshida S, Haque A, Mizobuchi T et al. Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants. Am J Transplant 2006 6 : 724 735.
6. Xu B, Wagner N, Pham LN et al. Lymphocyte homing to bronchus-associated lymphoid tissue (BALT) is mediated by L-selectin/PNAd, alpha4beta1 integrin/VCAM-1, and LFA-1 adhesion pathways. J Exp Med 2003 197 : 1255 1267.
7. Matloubian M, Lo CG, Cinamon G et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004 427 : 355 360.
8. Rosen H, Goetzl EJ. Sphingosine 1-phosphate and its receptors: An autocrine and paracrine network. Nat Rev Immunol 2005 5 : 560 570.
9. Sawicka E, Zuany-Amorim C, Manlius C et al. Inhibition of Th1- and Th2-mediated airway inflammation by the sphingosine 1-phosphate receptor agonist FTY720. J Immunol 2003 171 : 6206 6214.
10. Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, Chiba K. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J Immunol 1998 160 : 5493 5499.
11. Koshiba T, Van Damme B, Rutgeerts O, Waer M, Pirenne J. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A. Transplantation 2003 75 : 945 952.
12. Zhang Q, Chen Y, Fairchild RL, Heeger PS, Valujskikh A. Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival. J Immunol 2006 176 : 770 777.
13. Tedesco-Silva H, Mourad G, Kahan BD et al. FTY720, a novel immunomodulator: Efficacy and safety results from the first phase 2 A study in de novo renal transplantation. Transplantation 2004 77 : 1826 1833.
14. Graler MH, Huang MC, Watson S, Goetzl EJ. Immunological effects of transgenic constitutive expression of the type 1 sphingosine 1-phosphate receptor by mouse lymphocytes. J Immunol 2005 174 : 1997 2003.
15. Jolly PS, Rosenfeldt HM, Milstien S, Spiegel S. The roles of sphingosine-1-phosphate in asthma. Mol Immunol 2002 38 : 1239 1245.
16. Hale JJ, Neway W, Mills SG et al. Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720. Bioorg Med Chem Lett 2004 14 : 3351 3355.
17. Vachal P, Toth LM, Hale JJ et al. Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor. Bioorg Med Chem Lett 2006 16 : 3684 3687.
18. Hale JJ, Doherty G, Toth L et al. The discovery of 3-(N-alkyl) aminopropylphosphonic acids as potent S1P receptor agonists. Bioorg Med Chem Lett 2004 14 : 3495 3499.
19. Singer II, Tian M, Wickham LA et al. Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes. J Immunol 2005 175 : 7151 7161.
20. Webb M, Tham CS, Lin FF et al. Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice. J Neuroimmunol 2004 153 : 108 121.
21. Graler MH, Goetzl EJ. Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim Biophys Acta 2002 1582 : 168 174.
22. Huang MC, Watson SR, Liao JJ, Goetzl EJ. Th17 augmentation in OTII TCR plus T cell-selective type 1 sphingosine 1-phosphate receptor double transgenic mice. J Immunol 2007 178 : 6806 6813.
23. Jin Y, Knudsen E, Wang L et al. Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation. Blood 2003 101 : 4909 4915.
24. Haque MA, Mizobuchi T, Yasufuku K et al. Evidence for immune responses to a self-antigen in lung transplantation: Role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol 2002 169 : 1542 1549.
25. Yasufuku K, Heidler KM, O'Donnell PW et al. Oral tolerance induction by type V collagen downregulates lung allograft rejection. Am J Respir Cell Mol Biol 2001 25 : 26 34.
26. Yasufuku K, Heidler KM, Woods KA et al. Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Transplantation 2002 73 : 500 505.
27. Yousem SA, Berry GJ, Cagle PT et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996 15 : 1 15.
28. Swanson KA, Zheng Y, Heidler KM, Mizobuchi T, Wilkes DS. CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase. Am J Respir Cell Mol Biol 2004 30 : 311 318.
29. Prop J, Nieuwenhuis P, Wildevuur CR. Lung allograft rejection in the rat. I. Accelerated rejection caused by graft lymphocytes. Transplantation 1985 40 : 25 30.
30. Prop J, Wildevuur CR, Nieuwenhuis P. Lung allograft rejection in the rat. II. Specific immunological properties of lung grafts. Transplantation 1985 40 : 126 131.
31. Constant SL, Brogdon JL, Piggott DA et al. Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J Clin Invest 2002 110 : 1441 1448.
32. Moyron-Quiroz JE, Rangel-Moreno J, Kusser K et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 2004 10 : 927 934.
33. Brinkmann V, Cyster JG, Hla T. FTY720: Sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 2004 4 : 1019 1025.
34. Xie JH, Nomura N, Koprak SL, Quackenbush EJ, Forrest MJ, Rosen H. Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells. J Immunol 2003 170 : 3662 3670.
35. Kim YM, Sachs T, Asavaroengchai W, Bronson R, Sykes M. Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720. J Clin Invest 2003 111 : 659 669.
36. Liao JJ, Huang MC, Graler M, Huang Y, Qiu H, Goetzl EJ. Distinctive T cell-suppressive signals from nuclearized type 1 sphingosine 1-phosphate G protein-coupled receptors. J Biol Chem 2007 282 : 1964 1972.
37. Chi H, Flavell RA. Cutting edge: Regulation of T cell trafficking and primary immune responses by sphingosine 1-phosphate receptor 1. J Immunol 2005 174 : 2485 2488.
38. Dorsam G, Graeler MH, Seroogy C, Kong Y, Voice JK, Goetzl EJ. Transduction of multiple effects of sphingosine 1-phosphate (S1P) on T cell functions by the S1P1 G protein-coupled receptor. J Immunol 2003 171 : 3500 3507.
39. Wang W, Graeler MH, Goetzl EJ. Physiological sphingosine 1-phosphate requirement for optimal activity of mouse CD4+ regulatory T Cells. FASEB J 2004 18 : 1043 1045.
40. Rosen SD. Ligands for L-selectin: Homing, inflammation, and beyond. Annu Rev Immunol 2004 22 : 129 156.
41. Fukushima N, Ishii I, Contos JJ, Weiner JA, Chun J. Lysophospholipid receptors. Annu Rev Pharmacol Toxicol 2001 41 : 507 534.
42. Ishii I, Fukushima N, Ye X, Chun J. Lysophospholipid receptors: Signaling and biology. Annu Rev Biochem 2004 73 : 321 354.